Skip to main content
Top
Published in: Current Hematologic Malignancy Reports 4/2015

01-12-2015 | Social Media Impact of Hematologic Malignancies (N Pemmaraju, Section Editor)

Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider

Authors: Michael A. Thompson, Navneet S. Majhail, William A. Wood, Miguel-Angel Perales, Mélanie Chaboissier

Published in: Current Hematologic Malignancy Reports | Issue 4/2015

Login to get access

Abstract

Social media is a relatively new form of media that includes social networks for communication dissemination and interaction. Patients, physicians, and other users are active on social media including the microblogging platform Twitter. Many online resources are available to facilitate joining and adding to online conversations. Social media can be used for professional uses, therefore, we include anecdotes of physicians starting on and implementing social media successfully despite the limits of time in busy practices. Various applications demonstrating the utility of social media are explored. These include case discussions, patient groups, research collaborations, medical education, and crowdsourcing/crowdfunding. Social media is integrating into the professional workflow for some individuals and hematology/oncology societies. The potential for improving hematology care and research is just starting to be explored.
Appendix
Available only for authorised users
Literature
5.
go back to reference Katz MS, Utengen A, Anderson PF, Thompson MA, Atai DJ, Johnston C, Dizon DS. Organizing online health information with disease-specific hashtags. JAMA Oncol. In press. Katz MS, Utengen A, Anderson PF, Thompson MA, Atai DJ, Johnston C, Dizon DS. Organizing online health information with disease-specific hashtags. JAMA Oncol. In press.
8.••
go back to reference Katz M. The evolving role of healthcare professionals. SlideShare (Oct. 20, 2011) Available at: http://www.slideshare.net/subatomicdoc/medical-professionalism-10-20. Accessed August 14, 2015. Dr. Katz has provided many “how to” resources for getting started. He then expanded these 101-102-103 type introductions to promulgate an informatics “scaffold” for improving the signal-to-noise ratio of social media. Multiple references correlate with his integral involvement in helping others. Katz M. The evolving role of healthcare professionals. SlideShare (Oct. 20, 2011) Available at: http://​www.​slideshare.​net/​subatomicdoc/​medical-professionalism-10-20. Accessed August 14, 2015. Dr. Katz has provided many “how to” resources for getting started. He then expanded these 101-102-103 type introductions to promulgate an informatics “scaffold” for improving the signal-to-noise ratio of social media. Multiple references correlate with his integral involvement in helping others.
15.•
go back to reference Dizon DS, Graham D, Thompson MA, Johnson LJ, Johnston C, Fisch MJ, et al. Practical guidance: the use of social media in oncology. J Oncol Pract. 2012;8:e114–24. An early manuscript discussing the basics of social media and its risks, benefits and policies. PubMedCentralCrossRefPubMed Dizon DS, Graham D, Thompson MA, Johnson LJ, Johnston C, Fisch MJ, et al. Practical guidance: the use of social media in oncology. J Oncol Pract. 2012;8:e114–24. An early manuscript discussing the basics of social media and its risks, benefits and policies. PubMedCentralCrossRefPubMed
16.••
go back to reference Thompson MA. How can social media improve oncology care? Commun Oncol. 2013;10:212–7. A more pragmatic look at using social media. Thompson MA. How can social media improve oncology care? Commun Oncol. 2013;10:212–7. A more pragmatic look at using social media.
18.••
go back to reference Thompson MA. Using social media to learn and communicate: it is not about the tweet. Am Soc Clin Oncol Educ Book. 2015:206-11. A compilation of quotes, resources and thoughts for the #ASCO15 June 2015 meeting. Thompson MA. Using social media to learn and communicate: it is not about the tweet. Am Soc Clin Oncol Educ Book. 2015:206-11. A compilation of quotes, resources and thoughts for the #ASCO15 June 2015 meeting.
19.•
go back to reference Geske JB, Timimi FK. Social media starter kit and managing your digital reputation. Medscape Mayo Clinic Talks (March 23, 2015). Available at: http://www.medscape.com/viewarticle/841381. Accessed August 13, 2015. Information from leaders at a leading medical and social media forward-thinking institution – Mayo Clinic. Geske JB, Timimi FK. Social media starter kit and managing your digital reputation. Medscape Mayo Clinic Talks (March 23, 2015). Available at: http://​www.​medscape.​com/​viewarticle/​841381. Accessed August 13, 2015. Information from leaders at a leading medical and social media forward-thinking institution – Mayo Clinic.
20.•
go back to reference Eysenbach G. Can tweets predict citations? metrics of social impact based on Twitter and correlation with traditional metrics of scientific impact. J Med Internet Res. 2011;13:e123. Interesting and still unsettled thoughts on the ability to predict impact from social media. PubMedCentralCrossRefPubMed Eysenbach G. Can tweets predict citations? metrics of social impact based on Twitter and correlation with traditional metrics of scientific impact. J Med Internet Res. 2011;13:e123. Interesting and still unsettled thoughts on the ability to predict impact from social media. PubMedCentralCrossRefPubMed
22.
go back to reference Haustein S, Peters I, Sugimoto CR, Thelwall M, Larivière V. Tweeting biomedicine: an analysis of tweets and citations in the biomedical literature. J Assoc Inf Sci Technol. 2014;65:656–69.CrossRef Haustein S, Peters I, Sugimoto CR, Thelwall M, Larivière V. Tweeting biomedicine: an analysis of tweets and citations in the biomedical literature. J Assoc Inf Sci Technol. 2014;65:656–69.CrossRef
24.
go back to reference Thompson MA. Participatory medicine in oncology. ASCO Connection (Oct. 25, 2011). Available at: http://connection.asco.org/commentary/participatory-medicine-oncology. Accessed August 23, 2015. Thompson MA. Participatory medicine in oncology. ASCO Connection (Oct. 25, 2011). Available at: http://​connection.​asco.​org/​commentary/​participatory-medicine-oncology.​ Accessed August 23, 2015.
25.
go back to reference Thompson MA. Online patient communities for the e-patient: “betwixt and between” a new patient and an expert. ASCO Connection (Aug. 29, 2013). Available at: http://connection.asco.org/commentary/online-patient-communities-e-patient-“betwixt-and-between”-new-patient-and-expert. Accessed August 13, 2015. Thompson MA. Online patient communities for the e-patient: “betwixt and between” a new patient and an expert. ASCO Connection (Aug. 29, 2013). Available at: http://​connection.​asco.​org/​commentary/​online-patient-communities-e-patient-“betwixt-and-between”-new-patient-and-expert. Accessed August 13, 2015.
27.•
go back to reference Reid BB, Rodriguez KN, Thompson MA, Matthews GD. An analysis of cancer-specific Twitter conversations among physicians in 2013. J Clin Oncol (Meeting Abstracts). 2014;32(15_supp):e17644. Analysis of oncology tweets from MDs. Reid BB, Rodriguez KN, Thompson MA, Matthews GD. An analysis of cancer-specific Twitter conversations among physicians in 2013. J Clin Oncol (Meeting Abstracts). 2014;32(15_supp):e17644. Analysis of oncology tweets from MDs.
28.•
go back to reference Butcher L. Cancer-related crowdsourcing and crowdfunding move beyond the basics—with many active projects ongoing in myeloma. Oncol Times. 2015;37(10):18–20. Looks at crowd (=people) engagement in determining trial design and funding. This may help engage the public in science and fiscal policy around research. CrossRef Butcher L. Cancer-related crowdsourcing and crowdfunding move beyond the basics—with many active projects ongoing in myeloma. Oncol Times. 2015;37(10):18–20. Looks at crowd (=people) engagement in determining trial design and funding. This may help engage the public in science and fiscal policy around research. CrossRef
29.••
go back to reference Ekins S, Perlstein EO. Ten simple rules of live tweeting at scientific conferences. PLoS Comput Biol. 2014;10(8):e1003789. Great commentary to look at before conferences. PubMedCentralCrossRefPubMed Ekins S, Perlstein EO. Ten simple rules of live tweeting at scientific conferences. PLoS Comput Biol. 2014;10(8):e1003789. Great commentary to look at before conferences. PubMedCentralCrossRefPubMed
Metadata
Title
Social Media and the Practicing Hematologist: Twitter 101 for the Busy Healthcare Provider
Authors
Michael A. Thompson
Navneet S. Majhail
William A. Wood
Miguel-Angel Perales
Mélanie Chaboissier
Publication date
01-12-2015
Publisher
Springer US
Published in
Current Hematologic Malignancy Reports / Issue 4/2015
Print ISSN: 1558-8211
Electronic ISSN: 1558-822X
DOI
https://doi.org/10.1007/s11899-015-0286-x

Other articles of this Issue 4/2015

Current Hematologic Malignancy Reports 4/2015 Go to the issue

T-Cell and Other Lymphoproliferative Malignancies (P Porcu, Section Editor)

Molecular Pathogenesis of Peripheral T Cell Lymphoma

Myeloproliferative Disorders (C Harrison, Section Editor)

Setting Appropriate Goals for the Next Generation of Clinical Trials in Myelofibrosis

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.